CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients Who've run out of options
Disease control Recruiting nowThis early-stage trial is testing a new drug called ELVN-001 for chronic myeloid leukemia (CML). It aims to find the safest dose and see if the drug can reduce leukemia cells in patients whose current treatments have stopped working or caused severe side effects. The study includ…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New vaccine aims to shield vulnerable transplant patients from dangerous virus
Prevention Recruiting nowThis early-stage trial is testing a new vaccine designed to prevent serious cytomegalovirus (CMV) infections. The study involves patients with blood cancers who are receiving a stem cell transplant from a partially matched donor, a procedure that carries a high risk of CMV. Resea…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Apr 01, 2026 14:43 UTC